SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Albert Einstein — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientAlbert Einstein
Date of birth1879-03-14
IdentifiersMRN HR-ET012-SYN-TD; SSN (made up) 000-12-6650
Document date1949-09-22
AuthorClementine Ward, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-month aneurysm surveillance. [S]

History of Present Illness

Mr. Einstein returns six months after his first visit for surveillance duplex ultrasound, done in the vascular laboratory this morning. He has had no abdominal, back, flank, or groin pain, fainting, or leg symptoms. He finished the 7 mg nicotine patch this week and has used only an occasional lozenge, and has had no tobacco for nearly six months. His home blood pressure readings average 122/74. He takes amlodipine, losartan, atorvastatin, and aspirin without side effects. He has booked his eye examination and plans to have his influenza and COVID-19 vaccines at the pharmacy next week. He asked for the numbers in full and wanted to know whether anything in today's results changes the plan agreed in April. [S]

ElementDetail
Aneurysm5.1 cm by duplex ultrasound today; 5.0 cm six months ago
SymptomsNone
TobaccoTobacco-free nearly six months; nicotine replacement finished
Blood pressureHome average 122/74

Review of Systems

SystemResultFinding
CardiovascularNegativeNo fainting, chest pain, or leg pain on walking
GastrointestinalNegativeNo abdominal pain
MusculoskeletalNegativeNo back or flank pain; no muscle aches
RespiratoryNegativeNo cough

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet by mouth each morningOral route1948-05-20activeS
Losartan 50 mg oral tablet, one tablet dailyOne tablet by mouth each morningOral route1949-03-24 to 1949-04-21completedS
Losartan 100 mg oral tablet, one tablet dailyOne tablet by mouth each morningOral route1949-04-21activeS
Atorvastatin 40 mg oral tablet, one tablet dailyOne tablet by mouth each eveningOral route1949-03-24activeS
Aspirin 81 mg delayed-release oral tablet, one tablet dailyOne tablet by mouth daily with foodOral route1949-04-21activeS
Nicotine 14 mg/24 hour transdermal patch, one patch dailyApply one new patch each morningTopical route1949-03-24 to 1949-07-14completedS
Nicotine 7 mg/24 hour transdermal patch, one patch dailyApply one new patch each morningTopical route1949-07-14 to 1949-09-22completedS
Nicotine 2 mg lozenge as needed for cravingsDissolve one lozenge in the mouth for a craving, no more often than every 2 hours and no more than 20 a dayOral route1949-03-24 to 1949-09-22completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1949-09-22Body height172cmS
1949-09-22Body weight79.8kgS
1949-09-22Body mass index (BMI) [Ratio]27kg/m2S
1949-09-22Systolic blood pressure124mm[Hg]S
1949-09-22Diastolic blood pressure76mm[Hg]S
1949-09-22Heart rate66/minS
1949-09-22Respiratory rate14/minS
1949-09-22Body temperature36.6CelS
1949-09-22Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1949-09-22Aorta Diameter by US5.1cm<=3 cmHighS

Physical Exam

Vital signs recorded on 1949-09-22; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 79.8 kg
CardiovascularRegular rhythm at 66 per minute; blood pressure 124/76 mmHg; femoral, popliteal, and foot pulses normal
AbdomenPulsatile, non-tender mass above the umbilicus

Problems

ProblemClinical statusVerificationCodeProvenance
Infrarenal abdominal aortic aneurysm, 5.0 cm by duplex ultrasound, found and wrapped at a prior exploratory laparotomy; under surveillance below the repair thresholdactiveconfirmed I71.43S — Synthetic modern coding anchored to the documented aneurysm found and wrapped at his exploratory laparotomy; the diameter and all surveillance are synthetic.
Essential hypertensionactiveconfirmed I10S — Synthetic risk factor in the modern frame; no historical blood pressure is documented in the cited sources.
Nicotine dependence, pipe tobaccoactiveconfirmed F17.290S — Synthetic modern coding anchored to his documented pipe smoking.
Atherosclerosis of the abdominal aorta, with calcified atheroma on CT angiographyactiveconfirmed I70.0S — Synthetic finding on the baseline CT angiography.
Acute low back strain after lifting, with aneurysm symptoms excluded; resolvedresolvedconfirmed S39.012AS — Synthetic intercurrent illness at an unscheduled visit, chosen to teach how new back pain is assessed in a patient with a known aneurysm. It does not echo a documented illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ImagingAneurysm diameter by duplex ultrasound (CT if views are poor)Every 6 months at 5.0 to 5.4 cm in men; yearly at 4.0 to 4.9 cmCompleted today5.1 cm today, 5.0 cm six months ago: growth 0.1 cm; next scan in six months
ImagingCT angiography for baseline anatomy and repair planningOnce at baseline; again when repair is consideredUp to dateBaseline done; repeat only if repair is considered
ExaminationFemoral and popliteal arteries for a coexisting aneurysmOnce at diagnosisCompleted todayPopliteal duplex with today's scan: 0.8 cm on each side, no aneurysm
ExaminationAneurysm symptoms and tenderness, with the emergency plan reviewedEvery visitCompleted todayNo symptoms; non-tender; emergency plan reviewed
ReferralVascular surgery review and shared decision on elective repairAt baseline, then at a threshold change or yearlyCompleted todayThresholds and options reviewed with him today; preferences unchanged; report sent to vascular surgery, with review at one year
ExaminationBlood pressure, target below 130/80Every visitCompleted today124/76 mmHg; at target
Self-managementHome blood pressure readingsBefore each visit while treatment is being adjustedCompleted todayHome average 122/74
LaboratoryMetabolic panel (sodium, potassium, creatinine, eGFR)2 to 4 weeks after starting or changing losartan; then every 6 monthsUp to dateNormal ten weeks ago; next due in about four months, by standing order
LaboratoryLipid panel4 to 12 weeks after starting a statin; then yearlyUp to dateLDL 62 mg/dL ten weeks ago; repeat yearly
LaboratoryALTOnce before a statin; then only with symptomsNot indicatedNo symptoms
LaboratoryHbA1cYearlyUp to date5.6 percent six months ago; due at one year
LaboratoryUrine albumin-to-creatinine ratioYearlyUp to date14 mg/g six months ago; due at one year
Medication safetyStatin adherence and muscle symptomsEvery visitCompleted todayAdherent; no muscle aches
Medication safetyLow-dose aspirin: indication and bleedingEvery visit while taking itCompleted todayNo bleeding or bruising
Medication safetyMedication review: avoid fluoroquinolones and anti-inflammatory pain medicinesEvery visitCompleted todayNo anti-inflammatory or fluoroquinolone use
Self-managementTobacco use and cessation support (5 A's, nicotine replacement)Every visitCompleted todayTobacco-free nearly six months; nicotine replacement finished
Examination12-lead ECGBaseline with hypertension; repeat as indicatedUp to dateNormal five months ago
ExaminationAnkle-brachial indexEvery 2 to 3 years at 65 or older or with a smoking historyCompleted todayAnkle-brachial index with today's scan: 1.04 on the right and 1.02 on the left, normal
ExaminationEye examination for hypertensive retinopathyYearlyDueExamination booked for next month
ExaminationWeight and BMIEvery visitCompleted today79.8 kg; BMI 27.0

Goal progress:

Guideline basis: The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm (2018); 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease (2022); CMID: Clinical Monitoring Intelligence Database, Hypertension and Hyperlipidemia monographs (2026); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021)

Follow-up: Metabolic panel in about four months by standing order. Aneurysm surveillance with duplex ultrasound in six months. Vascular surgery review at one year. Annual wellness visit next summer. [S]